Business Context and Reporting Period
Company: The Brink's Company (Brink's)
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2026
Event: Entry into a Material Definitive Agreement (Merger Agreement) to acquire NCR Atleos Corporation.
Key Financial Metrics and Transaction Terms
Merger Consideration:
- Cash Component: $30.00 per share of NCR Atleos common stock.
- Stock Component: 0.1574 shares of Brink's common stock per share of NCR Atleos common stock.
- Fractional Shares: Paid in cash.
Financing Arrangements (Bridge Facilities):
- Base Bridge Facility: Up to $2,276 million in senior unsecured bridge term loans.
- NCR Atleos Term A Loan Backstop: Up to $873 million in senior secured bridge term loans (contingent on failure to refinance NCR Atleos Term A Loans).
- NCR Atleos Notes Backstop: Up to $1,350 million in senior secured bridge term loans (contingent on failure to amend/refinance NCR Atleos 2029 Notes).
Termination Fees:
- Fee Payable by NCR Atleos: $145,000,000 under specified circumstances (e.g., Superior Proposal, Outside Date expiration).
- Fee Payable by Brink's: $175,000,000 under specified circumstances (e.g., Parent Superior Proposal, Outside Date expiration).
Other Financial Data: The filing text does not provide specific revenue, profit, cash flow, or margin figures for the reporting period. It references Brink's 2025 10-K and NCR Atleos 2024 10-K/A for historical financial data.
Material Changes and Transaction Structure
Structure:
- First Merger: Novus Merger Sub, Inc. (Brink's subsidiary) merges with NCR Atleos; NCR Atleos survives as a Brink's subsidiary.
- Second Merger: Surviving NCR Atleos merges into Novus Merger Sub II, LLC (Brink's subsidiary); Novus Merger Sub II survives.
Equity Award Treatment:
- RSUs (Service-based): Converted to Brink's RSUs with adjusted share counts.
- PSUs (Performance-based): Converted to Brink's PSUs; performance deemed achieved based on actual results or 100% payout, whichever is greater.
- Options: Canceled and converted to cash equal to the excess of Merger Consideration over exercise price (if in-the-money).
Guidance, Outlook, Risks, and Contingencies
Closing Conditions:
- Stockholder approval from both NCR Atleos and Brink's.
- Regulatory approvals (including HSR Act waiting period expiration and foreign antitrust).
- Effectiveness of Brink's Form S-4 registration statement.
- NYSE listing authorization for Brink's shares to be issued.
- Absence of material adverse effects or legal restraints.
Key Risks and Contingencies:
- Financing Risk: Reliance on bridge financing; substantial indebtedness to be incurred.
- Integration Risk: Potential disruption to operations, customer relationships, and employee retention.
- Regulatory Risk: Failure to obtain necessary governmental consents or antitrust clearances.
- Termination Risk: Deal may terminate if the "Outside Date" (February 26, 2027, extendable to August 26, 2027) is not met or if stockholder approval is not obtained.
Outlook: Management intends to realize anticipated benefits and synergies, though actual results may differ due to integration challenges and economic conditions.
Important Facts for Investor Verification
- Valuation Mix: Verify the total value of the consideration ($30.00 cash + 0.1574 Brink's shares) based on current Brink's stock price.
- Debt Load: Confirm the total potential debt exposure of up to $4.5 billion in bridge facilities if backstop conditions are triggered.
- Shareholder Approval: Monitor the upcoming proxy statements and voting results for both companies.
- Regulatory Timeline: Track the status of antitrust reviews and the HSR waiting period.
- Termination Triggers: Review the specific conditions under which the $145 million or $175 million termination fees would be payable.
- Equity Plan Assumption: Verify the final terms of the converted equity awards for NCR Atleos employees.